Activation of NF-κB signaling is often observed in CRC, and this pathway plays a critical role in facilitating oncogenesis and metastasis and in mediating resistance to chemotherapy and radiation therapy [24]. The gene discussed is NFKB1; the disease is colorectal carcinoma.